Healthcare Capital Corp. Class A common stock
HCCC
HCCC was delisted on the 7th of March, 2022.
0 hedge funds and large institutions have $0 invested in Healthcare Capital Corp. Class A common stock in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 81 closing their positions.
100% less funds holding
Funds holding: 81 → 0 (-81)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $249M → $0 (-$249M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 81
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
-$21.1M |
| 2 |
LA
Linden Advisors
New York
|
-$14.1M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$13.1M |
| 4 |
CI
Clal Insurance
Tel-Aviv,
Israel
|
-$11.8M |
| 5 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$10.5M |
HCCC Hedge Fund Activity: Q1 2022 in Review
0 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Healthcare Capital Corp. Class A common stock (HCCC) for Q1 2022, worth a combined $0 — down 100% from $249M a quarter earlier.
Sellers outnumbered buyers: 81 funds closed out of HCCC and 0 opened new positions — a net loss of 81 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Weiss Asset Management, exiting entirely with an estimated $21.1M sold.
- 0 institutional investors held Healthcare Capital Corp. Class A common stock (HCCC) as of Q1 2022, down from 81 in Q4 2021.
- Funds reported $0 of Healthcare Capital Corp. Class A common stock stock for Q1 2022, down 100% quarter-over-quarter.
- 0 funds opened new Healthcare Capital Corp. Class A common stock positions in Q1 2022 and 81 closed out, a net change of -81 holders.
- The largest Healthcare Capital Corp. Class A common stock seller in Q1 2022 was Weiss Asset Management, an estimated $21.1M sold.
Based on aggregated 13F filings for Q1 2022.